Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial.
第一作者:
Rebecca M,Reynolds
第一单位:
British Heart Foundation Centre for Cardiovascular Science Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. r.reynolds@ed.ac.uk.;Tommy's Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. r.reynolds@ed.ac.uk.
作者:
医学主题词
成年人(Adult);血糖(Blood Glucose);糖尿病, 妊娠(Diabetes, Gestational);药物疗法, 联合(Drug Therapy, Combination);可行性研究(Feasibility Studies);女(雌)性(Female);格列本脲(Glyburide);人类(Humans);降血糖药(Hypoglycemic Agents);胰岛素(Insulin);服药依从性(Medication Adherence);二甲双胍(Metformin);病人遴选(Patient Selection);妊娠(Pregnancy)
DOI
10.1186/s12884-017-1505-3
PMID
28938877
发布时间
2025-05-30
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



